Marco Smit

Marco Smit has held various leadership roles in the healthcare and technology industries. Marco is currently the Vice President of Business Development at Gesund.ai, where they focus on making medical AI more accessible and applicable in the life sciences and healthcare sectors. Prior to that, they served as the VP, Head of Data and AI at Caresyntax, overseeing the company's transition to software and real-world data solutions.

Marco's experience also includes working as a Start-up Board Advisor at StartX, UCSF Global Life Sciences/Healthcare Entrepreneurship Program, where they mentored and advised young insurtech, healthtech, AI, and data/RWE companies on product management, business development, and fundraising. Marco also held the position of Director Of Global Business Development and M&A at Roche, where they led partnerships and M&A projects for data and AI initiatives in healthcare.

Earlier in their career, Marco served as the Chief Executive Officer at HealthExpense, Inc., leading the development of an integrated healthcare payments platform. Marco also advised Lynx Biosciences on precision medicine solutions, and founded Next Innovation Health Partners, where they helped healthcare incumbents identify and collaborate with startups. Marco's extensive experience includes roles at Health 2.0 Advisors, Affymetrix, and Spectral Genomics, where they contributed to strategic marketing, business development, and product strategy.

Throughout their career, Marco has demonstrated a strong focus on driving innovation and growth in healthcare, leveraging technologies such as AI, data, and real-world evidence to improve patient engagement and clinical decision-making.

Marco Smit obtained their M.Sc. degree in Economics from Erasmus University Rotterdam, where they studied from 1989 to 1995. Additionally, they attended ESSEC Business School from 1993 to 1994, although specific information regarding their degree or field of study at this institution is not provided.